35 results
424B3
KPRX
Kiora Pharmaceuticals Inc
28 Mar 24
Prospectus supplement
4:48pm
and challenges in our business and the market in which we operate;
the impact of the evolving COVID-19 pandemic; and
our use of proceeds from
424B1
KPRX
Kiora Pharmaceuticals Inc
2 Jun 23
Prospectus with pricing info
5:08pm
on our ability to retain key executives and to attract, retain, and motivate qualified personnel.
The coronavirus pandemic could adversely impact our … irregularities or errors or to facilitate the fair presentation of our consolidated financial statements.
General Risk Factors
The coronavirus pandemic could
424B3
tex58fgbm ki
28 Dec 22
Prospectus supplement
4:48pm
424B1
nf83dr
22 Jul 22
Prospectus with pricing info
6:00pm
10-K/A
h5su5gxg p2
6 Jul 22
Annual report (amended)
5:34pm